2) The Oral Glucose Tolerance Test (OGTT) evaluates blood sugar levels two hours post-consumption of a 75 g glucose solution.

UTR Therapeutics plans to initiate a Phase 1 trial of UTRxM1-18 in patients with advanced c-MYC–driven tumors pending regulatory approvals. The company is also exploring translational and commercial ...

Cambridge-based startup CuspAI, which has just unveiled $100 million funding from global investors, was named Business of the ...

The biotechnology sector is entering a period of rapid growth and meaningful innovation. Global biotech revenue is expected to expand at roughly 13 to 14% annually over the next decade, moving from ...

Half Year ResultsNewron presents H1 2025 results and provides business update 16.09.2025 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Newron presents H1 2025 ...

This release is being retransmitted for extra exposure to downstream sites. SHELTON, CT / ACCESS Newswire / September 11, ...

Nordisk and Eli Lilly are set to reshape the oral GLP-1 market as patient demand grows and new therapies emerge. Learn more ...

Indian Patent granted for proprietary Plant-Based Vitamin D3 manufacturing process created in-house by Fermenta's R and D • Strengthens Fermenta's IP portfolio and leadership in sustainable Vitamin D3 ...

University of Sheffield is inviting applications for BSc Biomedical course that starts from September 2026. The course ...

SHELTON, CONNECTICUT / ACCESS Newswire / September 9, 2025 / NanoViricides, Inc. (NYSE American:NNVC ) (the “Company”), a ...

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 ...